Clinical Trial Update: Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer [NA]

View source ↗

Summary

A clinical trial is assessing moderate hypofractionated boost to the prostate with pelvic radiotherapy for high-risk prostate cancer and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | NA | Status: RECRUITING